Cite
Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma
MLA
Sung Won Lee, et al. “Entecavir versus Tenofovir in Patients with Chronic Hepatitis B: Enemies or Partners in the Prevention of Hepatocellular Carcinoma.” Clinical and Molecular Hepatology, vol. 27, no. 3, July 2021, pp. 402–12. EBSCOhost, https://doi.org/10.3350/cmh.2021.0179.
APA
Sung Won Lee, Jonggi Choi, Seung Up Kim, & Young-Suk Lim. (2021). Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma. Clinical and Molecular Hepatology, 27(3), 402–412. https://doi.org/10.3350/cmh.2021.0179
Chicago
Sung Won Lee, Jonggi Choi, Seung Up Kim, and Young-Suk Lim. 2021. “Entecavir versus Tenofovir in Patients with Chronic Hepatitis B: Enemies or Partners in the Prevention of Hepatocellular Carcinoma.” Clinical and Molecular Hepatology 27 (3): 402–12. doi:10.3350/cmh.2021.0179.